000 | 01950 a2200529 4500 | ||
---|---|---|---|
005 | 20250513184725.0 | ||
264 | 0 | _c19990909 | |
008 | 199909s 0 0 eng d | ||
022 | _a0891-5849 | ||
024 | 7 |
_a10.1016/s0891-5849(98)00331-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLemaire, G | |
245 | 0 | 0 |
_aDifferential cytostatic effects of NO donors and NO producing cells. _h[electronic resource] |
260 |
_bFree radical biology & medicine _cMay 1999 |
||
300 |
_a1274-83 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aCell Division _xdrug effects |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aDNA, Neoplasm _xbiosynthesis |
650 | 0 | 4 |
_aDeoxyadenine Nucleotides _xmetabolism |
650 | 0 | 4 |
_aDeoxyribonucleotides _xmetabolism |
650 | 0 | 4 |
_aFree Radicals _xmetabolism |
650 | 0 | 4 |
_aGlutathione _xmetabolism |
650 | 0 | 4 |
_aGlyceraldehyde-3-Phosphate Dehydrogenases _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMacrophages _xmetabolism |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNeoplasms, Experimental _xdrug therapy |
650 | 0 | 4 |
_aNitric Oxide _xbiosynthesis |
650 | 0 | 4 |
_aNitric Oxide Donors _xpharmacology |
650 | 0 | 4 |
_aNitric Oxide Synthase _xmetabolism |
650 | 0 | 4 | _aNitric Oxide Synthase Type II |
650 | 0 | 4 | _aNitrogen Oxides |
650 | 0 | 4 |
_aPenicillamine _xanalogs & derivatives |
650 | 0 | 4 |
_aRibonucleotide Reductases _xmetabolism |
650 | 0 | 4 |
_aSpermine _xanalogs & derivatives |
650 | 0 | 4 |
_aTriazenes _xpharmacology |
650 | 0 | 4 | _aTumor Cells, Cultured |
700 | 1 | _aAlvarez-Pachon, F J | |
700 | 1 | _aBeuneu, C | |
700 | 1 | _aLepoivre, M | |
700 | 1 | _aPetit, J F | |
773 | 0 |
_tFree radical biology & medicine _gvol. 26 _gno. 9-10 _gp. 1274-83 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0891-5849(98)00331-1 _zAvailable from publisher's website |
999 |
_c10339626 _d10339626 |